Skip to main content

Market Overview

E. Coli Scare Could Cut Chipotle Earnings By 5% This Quarter, Estimates Say

Share:
E. Coli Scare Could Cut Chipotle Earnings By 5% This Quarter, Estimates Say
  • Chipotle Mexican Grill, Inc. (NYSE: CMG) has seen a 16.08 percent decline in its share price over the past three months, with a low of $624 on November 2.
  • Piper Jaffray’s Nicole Miller Regan has reiterated an Overweight rating and price target of $737 on the company.
  • Although the recent E. coli issue is expected to pressure the stock in the near term, Regan believes that the recent pullback in the shares offers an attractive entry point for “patient” investors.

Analyst Nicole Miller Regan mentioned that there had been reports regarding an E. coli issue in the company’s Pacific Northwest stores.

According to the Piper Jaffray report, “Operational protocols are being executed in perfect alignment with the Chipotle brand equity.”

Related Link: Short-Term Chipotle Investors Lose From E. Coli Outbreak; Is Your Portfolio At Risk?

Regan believes that the stock could remain pressured until there is more news and information regarding the E. coli issue, although she expressed optimism regarding Chipotle Mexican Grill’s “operational protocols and quick reaction time.”

Although there has been no information regarding where the bacteria actually originated, Regan mentioned that the company has been conservative in closing stores “above and beyond” those that were likely to have been impacted in an attempt to limit any further impact.

“In the meantime, we believe the company is working to assess, identify, and correct the current situation while also actively managing relations with both guests and Chipotle team members,” Regan stated.

On the other hand, the store closures could adversely impact the 4Q15 earnings by 5 percent, if the closed stores remain closed through the year without any additional closures.

Regan believes that Chipotle Mexican Grill’s robust balance sheet supports share buybacks, which in turn could prove to be a near term catalyst for the stock.

Latest Ratings for CMG

DateFirmActionFromTo
Feb 2022Morgan StanleyMaintainsOverweight
Feb 2022Deutsche BankMaintainsHold
Feb 2022BarclaysMaintainsEqual-Weight

View More Analyst Ratings for CMG

View the Latest Analyst Ratings

 

Related Articles (CMG)

View Comments and Join the Discussion!

Posted-In: Nicole Miller ReganAnalyst Color Long Ideas Reiteration Restaurants Analyst Ratings Trading Ideas General Best of Benzinga

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com